© 1994 British Society for Rheumatology
research-article |
HYALURONAN CONCENTRATION IN NON-INFLAMED AND RHEUMATOID SYNOVIUM
*The Synovial Biology Group, Department of Medicine, University College London
The Kennedy Institute of Rheumatology London
Correspondence to:
A. Pitsillides, Department of Rheumatology, Arthur Stanley House, Tottenham Street, London W1P 9PG, UK.
The concentration of hyaluronan was measured by a novel application of an ELISA technique, using biotinylated hyaluronan binding-region (HABr) derived from cartilage proteoglycan core-protein, to digested frozen sections of synovium. The relative extractability of hyaluronan, from sections of synovium by short-term washes in buffer, was assessed by the same method. The distribution of hyaluronan in adjacent sections was assessed histochemically using the biotinylated HABr and alkaline phosphatase-conjugated streptavidin. Hyaluronan concentrations were lower in rheumatoid synovium (0.71 ± 0.10 mg/cm3; mean ± S.E.M.) than in non-inflamed synovium (1.07 ± 0.16 mg/cm3). However, the ratio of extractable or ‘free’ hyaluronan to non-extractable or ‘bound’ hyaluronan, was greatly increased in rheumatoid synovium, being 4.53 ± 0.40 (mean ± S.E.M.) compared with 1.87 ± 0.42 in non-inflamed synovium. Histochemical staining showed hyaluronan to be concentrated in the lining layer of non-inflamed samples, whereas in rheumatoid synovium the stain was more uniformly distributed throughout the tissue. Although the total concentration of hyaluronan was not increased in rheumatoid synovium, the increased proportion of ‘free’, and therefore presumably mobile, hyaluronan molecules together with increased synovial bulk may contribute to the known increases in serum levels of hyaluronan in patients with RA.
KEY WORDS: Synovium, Hyaluronan, Serum, Enzyme-linked immunoassay
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. C. Lewthwaite, E. R. Bastow, K. J. Lamb, J. Blenis, C. P. D. Wheeler-Jones, and A. A. Pitsillides A Specific Mechanomodulatory Role for p38 MAPK in Embryonic Joint Articular Surface Cell MEK-ERK Pathway Regulation J. Biol. Chem., April 21, 2006; 281(16): 11011 - 11018. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Lesley, I. Gal, D. J. Mahoney, M. R. Cordell, M. S. Rugg, R. Hyman, A. J. Day, and K. Mikecz TSG-6 Modulates the Interaction between Hyaluronan and Cell Surface CD44 J. Biol. Chem., June 11, 2004; 279(24): 25745 - 25754. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H Xu, J Edwards, S Banerji, R Prevo, D G Jackson, and N A Athanasou Distribution of lymphatic vessels in normal and arthritic human synovial tissues Ann Rheum Dis, December 1, 2003; 62(12): 1227 - 1229. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kawakami, K. Suzuki, Y. Matsuki, T. Ishizuka, T. Hidaka, T. Konishi, M. Matsumoto, K. Kataharada, and H. Nakamura Hyaluronan production in human rheumatoid fibroblastic synovial lining cells is increased by interleukin 1beta but inhibited by transforming growth factor beta 1 Ann Rheum Dis, October 1, 1998; 57(10): 602 - 605. [Abstract] [Full Text]
|
|
|
|
 |
|
 P J Coleman, D Scott, A Abiona, D E Ashhurst, R M Mason, and J R Levick Effect of depletion of interstitial hyaluronan on hydraulic conductance in rabbit knee synovium J. Physiol., June 15, 1998; 509(3): 695 - 710. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. L. McGeer, M. Schulzer, and E. G. McGeer Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: A review of 17 epidemiologic studies Neurology, August 1, 1996; 47(2): 425 - 432. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Andersen, L. J. Launer, A. Ott, A.W. Hoes, M.M.B. Breteler, and A. Hofman Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease?: The Rotterdam Study Neurology, August 1, 1995; 45(8): 1441 - 1445. [Abstract] [Full Text] [PDF]
|
|